Liabilities of NeuroSense Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: NeuroSense Therapeutics Ltd. quarterly Liabilities in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
NeuroSense Therapeutics Ltd. Liabilities for the quarter ending 30 Jun 2025 was $2,203,000, a 38% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Change (%)

NeuroSense Therapeutics Ltd. Quarterly Liabilities (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$2,203,000	-$1,341,000	-38%	30 Jun 2025	6-K	01 Aug 2025	2025	Q2
Q4 2024	$1,992,000	-$2,952,000	-60%	31 Dec 2024	6-K	01 Aug 2025	2025	Q2
Q2 2024	$3,544,000	-$5,869,000	-62%	30 Jun 2024	6-K	30 Sep 2024	2024	Q2
Q4 2023	$4,944,000	+$3,071,000	+164%	31 Dec 2023	20-F	07 Apr 2025	2024	FY
Q4 2022	$1,873,000	-$552,000	-23%	31 Dec 2022	6-K	17 Jun 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.